Real-world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa.

Saved in:
Bibliographic Details
Title: Real-world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa.
Authors: Hou PC; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan., Aala W Jr; Institute of Clinical Medicine College of Medicine National Cheng Kung University Tainan Taiwan., Tu WT; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan., McGrath JA; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan.; St John's Institute of Dermatology School of Basic and Medical Biosciences King's College London London UK., Hsu CK; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan.; Institute of Clinical Medicine College of Medicine National Cheng Kung University Tainan Taiwan.; International Center for Wound Repair and Regeneration National Cheng Kung University Tainan Taiwan.
Source: Skin health and disease [Skin Health Dis] 2024 Aug 19; Vol. 4 (5), pp. e445. Date of Electronic Publication: 2024 Aug 19 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9918227353706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2690-442X (Electronic) Linking ISSN: 2690442X NLM ISO Abbreviation: Skin Health Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2690-442X
DOI:10.1002/ski2.445